SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 1st, 2021 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of March 1, 2021 (the “Effective Date”) is entered into by and between Atabak Mokari, Chief Financial Officer (“CFO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • November 8th, 2011 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 8th, 2011 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 1, 2011 (the “Effective Date”) is entered into by and between G. Charles Robb, Chief Financial Officer (“CFO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).